The Effect of Medication Reminder Technology on Medication Adherence and Hypertension Outcomes

This study is currently recruiting participants.
Verified June 2013 by Purdue University
Sponsor:
Information provided by (Responsible Party):
Alan Zillich Lab, Purdue University
ClinicalTrials.gov Identifier:
NCT01755312
First received: December 18, 2012
Last updated: June 12, 2013
Last verified: June 2013
  Purpose

This study to evaluates how a med reminder affects the patient's ability to take medications as prescribed


Condition Intervention
Medication Adherence
Blood Pressure
Device: Medication reminder

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: The Effect of Medication Reminder Technology on Medication Adherence and Hypertension

Resource links provided by NLM:


Further study details as provided by Purdue University:

Primary Outcome Measures:
  • self-reported medication adherence using the Morisky 8-Item Medication Adherence Scale(MMAS-8) tool [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • systolic blood pressure in mmHg using a valid automated device [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 240
Study Start Date: June 2013
Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: medication reminder
medication reminder
Device: Medication reminder
Medication reminder
Placebo Comparator: Placebo
Placebo

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • poor medication adherence
  • high blood pressure

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01755312

Contacts
Contact: Alan Zilllich, PharmD 317-613-2315 ext 320 azillich@purdue.edu

Locations
United States, Indiana
Purdue University Recruiting
West Lafayette, Indiana, United States, 47906
Contact: Alan Zillich, PharmD    317-613-2315 ext 320    azillich@purdue.edu   
Principal Investigator: Alan Zillich, PharmD         
Sponsors and Collaborators
Purdue University
  More Information

No publications provided

Responsible Party: Alan Zillich Lab, Associate Professor Pharmacy Practice, Purdue University
ClinicalTrials.gov Identifier: NCT01755312     History of Changes
Other Study ID Numbers: 2r44ago39178-02 (1208012596)
Study First Received: December 18, 2012
Last Updated: June 12, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on April 14, 2014